Smith & Nephew stock faces a USD 350 million debt redemption
Published on 10/04/2026 at 19:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Smith & Nephew stock (ISIN US83175M2052) was last at USD 26.42 on the NYSE on October 2, 2026, down 0.60 percent from the prior close. The company is preparing to redeem USD 350 million of 5.150 percent notes due 2027 on October 5, 2026, according to the SEC filing dated September 18, 2026.
Debt redemption sets the near term
The notes will be redeemed at a price calculated under the indenture, and interest will stop accruing on the redemption date. The filing also says the securities listing on the New York Stock Exchange will be canceled on or shortly after October 5, 2026.
The scheduled payment concerns the company's debt rather than its ordinary shares. For equity investors, the more material operating question is whether stronger profit conversion can offset slower sales growth in the medical-device business.
Profit grew faster than revenue
Smith & Nephew reported H1 2026 revenue of USD 3.097 billion for the six months ended June 27, 2026, up 4.6 percent from USD 2.961 billion a year earlier. Trading profit increased 8.1 percent to USD 566 million, and the trading profit margin expanded to 18.3 percent from 17.7 percent, according to MetaTrader's H1 2026 financial summary.
Adjusted EPS rose 11.0 percent to 47.7 cents from 42.9 cents, while cash from operations increased 6.9 percent to USD 605 million. The contrast gives the stock a clear operating tension: margin gains are outpacing top-line growth, but the company still needs improved demand in key orthopedic markets.
Analysts see upside to USD 31.91
MarketBeat reports a Hold consensus from 12 analysts, comprising one Buy, ten Hold and one Sell rating. Its consensus price target is USD 31.91, which lies 20.8 percent above the October 2, 2026 price of USD 26.42.
MarketBeat also cites a USD 26.38 intraday low and a prior close of USD 26.96 on October 1, 2026. The stock's 50-day moving average was USD 29.14 and its 200-day moving average was USD 30.42, placing the latest quote below both technical reference levels.
Smith & Nephew stock stays below its yearly high
Smith & Nephew stock was last at USD 26.42 on the NYSE on October 2, 2026 at 4:00 p.m. ET. Its market capitalization was USD 11.1 billion, with a session range of USD 26.09 to USD 26.50 and a 52-week range of USD 26.12 to USD 37.51.
Smith & Nephew stock facts
- Company: Smith & Nephew plc
- ISIN: US83175M2052
- Ticker: SNN
- Trading venue: NYSE
- Price (as of October 2, 2026, 4:00 p.m. ET): USD 26.42
- Market capitalization: USD 11.1 billion (as of October 2, 2026)
- 52-week range: USD 26.12-37.51 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Devices
